| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.68(B) |
| Last
Volume: |
270,299 |
Avg
Vol: |
187,424 |
| 52
Week Range: |
$81.08 - $194.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
28,542 |
1,746,822 |
1,815,401 |
1,818,359 |
| Total Sell Value |
$2,942,495 |
$185,216,328 |
$197,313,260 |
$197,870,049 |
| Total People Sold |
5 |
8 |
9 |
9 |
| Total Sell Transactions |
8 |
15 |
19 |
24 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2020-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,376) |
7,561 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2020-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,616 |
8,320 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2020-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(377) |
345 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2020-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
722 |
722 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2020-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(529) |
532 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,006 |
1,061 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2020-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(529) |
16,274 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,006 |
16,803 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(356) |
5,200 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
805 |
5,556 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,282 |
4,751 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-02-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,010) |
2,469 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2020-02-03 |
4 |
AS |
$182.13 |
$452,957 |
D/D |
(2,487) |
55 |
|
-2% |
|
| Swinney Robert S |
Director |
– • – |
2020-01-30 |
4 |
AS |
$184.07 |
$49,331 |
D/D |
(268) |
19,704 |
|
-0% |
|
| Swinney Robert S |
Director |
– • – |
2020-01-30 |
4 |
OE |
$32.40 |
$48,600 |
D/D |
1,500 |
19,972 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-01-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(999) |
3,479 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,181 |
4,478 |
|
- |
|
| Mccall Thomas D |
Vice President and Genl Mgr. |
• – – |
2020-01-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,698) |
7,841 |
|
- |
|
| Mccall Thomas D |
Vice President and Genl Mgr. |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,153 |
9,539 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2020-01-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,845) |
6,321 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
9,166 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2020-01-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,846) |
15,797 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
18,643 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2020-01-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,847) |
2,542 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
5,389 |
|
- |
|
1485 Records found
|
|
Page 12 of 60 |
|
|
3.83 (3.54%) 
